Condition

Hepatitis C Infection (2)

Chronic Hepatitis (1)

HIV Infection (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Inovio Pharmaceuticals (1)

Intervention

electroporation-mediated plasmid dna vaccine therapy (1)

hcv dna vaccine ino-8000 (1)

laboratory biomarker analysis (1)

nitazoxanide (ntz) (1)

pegylated interferon alfa-2a (peg) (1)

quality-of-life assessment (1)

ribavirin (rbv) (1)

rocakinogene sifuplasmid (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

Hepatitis C Infection

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting

Chronic Hepatitis
Hepatitis C Infection

Electroporation-Mediated Plasmid DNA Vaccine Therapy
+4 more

Jacksonville, Florida
+4 more

Sep 20, 2022

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed

Has Results

HIV Infection
Hepatitis C Infection

Nitazoxanide (NTZ)
+2 more

Birmingham, Alabama
+17 more

Nov 2, 2021